Tissue heart valves: Current challenges and future research perspectives

Journal of Biomedical Materials Research

Volumn 47, Issue 4, 1997, Pages 439-465

  Schoen, Frederick J ^a   Levy, Robert J ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; BIOLOGICAL MEMBRANES; BIOMEDICAL ENGINEERING; CADAVERIC EXPERIMENTS; CALCIFICATION (BIOCHEMISTRY); COLLAGEN; ENGINEERING RESEARCH; GRAFTS; IMPLANTS (SURGICAL); PROTEINS; TISSUE; TRANSPLANTATION (SURGICAL);

ALLOGRAFTS; BOVINE PERICARDIAL VALVES; ELASTEN; TISSUE ENGINEERING;

HEART VALVE PROSTHESES;

ALCOHOL; ALUMINUM CHLORIDE; CALCIUM; CALCIUM PHOSPHATE; COLLAGEN; DODECYL SULFATE SODIUM; ELASTIN; ETIDRONIC ACID; FERROUS CHLORIDE; GLUTARALDEHYDE; MEMBRANE PROTEIN; OLEIC ACID; PHOSPHOLIPID; BIOMATERIAL;

ALLOGRAFT; BIOENGINEERING; CALCIFICATION; CALCIUM CELL LEVEL; CATTLE; CONFERENCE PAPER; DETERIORATION; GRAFT FAILURE; GRAFT SURVIVAL; HEART VALVE BIOPROSTHESIS; HEART VALVE REGURGITATION; HEART VALVE REPLACEMENT; HEART VALVE STENOSIS; MINERALIZATION; SWINE; ANIMAL; BIOPROSTHESIS; FORECASTING; HEART VALVE PROSTHESIS; HUMAN; REVIEW;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOPROSTHESIS; CATTLE; FORECASTING; HEART VALVE PROSTHESIS; HUMANS;

EID: 0033572873     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O     Document Type: Conference Paper

References (191)

1. Harken DF, Taylor WJ, LeFemine AA, Lefemine AA, Lunzer S, Low HB, Cohen ML, Jacobey JA. Aortic valve replacement with a caged ball valve. Am J Cardiol 1962;9:292-299.
2. Grunkemeier GL, Rahimtoola SH. Artificial heart valves. Annu Rev Med 1990;41:251-263.
3. Jamieson WR. Modern cardiac valve devices - bioprostheses and mechanical prostheses: state of the art. J Cardiac Surg 1993;8:89-98.
4. Schoen FJ, Levy RJ, Piehler HR. Pathological considerations in replacement cardiac valves. Cardiovasc Pathol 1992;1:29-52.
5. Turina J, Hess OM, Turina M, Krayenbuehl HP. Cardiac bioprostheses in the 1990s. Circulation 1993;88:775-781.
6. Vongpatanasin W, Hillis D, Lange RA. Prosthetic heart valves. N Engl J Med 1996;335:407-416.
7. Schoen FJ. Approach to the analysis of cardiac valve prostheses as surgical pathology or autopsy specimens. Cardiovasc Pathol 1995;4:241-255.
8. Ross D. Homograft replacement of the aortic valve. Lancet 1962;2:487.
9. Barratt-Boyes BG. Homograft aortic valve replacement in aortic incompetence and stenosis. Thorax 1964;19:131.
10. Carpentier A, Deloche A, Relland J, Fabiani JN, Forman J, Camilleri JP, Soyer R, Dubost C. Six-year follow-up of glutar-aldehyde-preserved heterografts: with particular reference to the treatment of congenital valve malformations. J Thorac Cardiovasc Surg 1974;68:771-782.
11. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC. Twelveyear comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med 1991;324:573-579.
12. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with mechanical valve or bioprosthesis. N Engl J Med 1993;328:1289-1296.
13. Schoen FJ. Interventional and surgical cardiovascular pathology: clinical correlations and basic principles. Philadelphia: WB Saunders; 1989.
14. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-935.
15. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635-641.
16. Senning A. Fascia lata replacement of aortic valves. J Thorac Cardiovasc Surg 1967;54:465-470.
17. Puig LB, Verginelli G, Iryia K, Kawabe L, Bellotti G, Sosa E, Pilleggi F, Zerbini EJ. Homologous dura mater cardiac valves. J Thorac Cardiovasc Surg 1975;69:722-728.
18. Yun KL, Miller C, Moore KA, Mitchell RS, Oyer PE, Stinson EB, Robbins RC, Reitz BA, Shumway NE. Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses. Ann Thorac Surg 1995;60:S221-S228.
19. Gross L, Kugel MA. Topographic anatomy and histology of the valves in the human heart. Am J Pathol 131;7:445-456.
20. Mohri H, Reichenbach DD, Merendino KA. Biology of homologous and heterologous aortic valves. In: Ionescu MI, Ross DN, Wooler G, editors. Biological tissue in heart valve replacement. London: Buttersworth; 1972. p 137-194.
21. Ferrans VJ, Spray TL, Billingham ME, Roberts WC. Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves: transmission and scanning electron microscopic observations in 12 patients. Am J Cardiol 1978;41:1159-1184.
22. Sauren AAHJ , Kuijpers W, Steenhoven AAV, Veldpaus FE. Aortic valve histology and its relation with mechanics: preliminary report. J Biomech 1980;13:97-104.
23. Schoen FJ. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis 1997;6:1-6.
24. Broom N, Christie GW. The structure/function relationship of fresh and glutaraldehyde-fixed aortic valve leaflets. In: Conn LH, Gallucci V, editors. Cardiac bioprostheses: proceedings of the Second International Symposium. New York: Yorke Medical Books; 1982. p 476-491.
25. Filip DA, Radu A, Simionescu M, Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res 1986;59:310-320.
26. Messier RH, Bass BL, Aly AM, Jones JL, Domkowski PW, Wallace RB, Hopkins RA. Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. J Surg Res 1994;57: 1-21.
27. Mulholland DL, Gotlieb AI. Cell biology of valvular interstitial cells. Can J Cardiol 1996;12:231-236.
28. Mulholland DL, Gotlieb AI. Cardiac valve interstitial cells: regulator of valve structure and function. Cardiovasc Pathol 1997;6:167-174.
29. Peskin CS, McQueen DM. Mechanical equilibrium determines the fractal fiber architecture of aortic heart valve leaflets. Am J Physiol 1994;266:H319-H328.
30. Scott MJ, Vesely I. Morphology of porcine aortic valve cusp elastin. J Heart Valve Dis 1996;5:464-471.
31. Vesely I. The role of elastin in aortic valve mechanics. J Biomech 1998;31:115-123.
32. Grunkemeier GL, Bodnar E. Comparison of structural valve failure among different "models" of homograft valves. J Heart Valve Dis 1994;3:556-560.
33. Woodruf EA. The chemistry and biology of aldehyde treated tissue heart valve xenografts. In: Ionescu MI, editor. Tissue heart valves. London: Butterworth; 1979. p 347-362.
34. Jayakrishnan A, Jameela SR. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. Biomaterials 1996; 17:471-484.
35. Bortolotti U, Talenti E, Milano A, Thiene G, Gallucci V. Formaldehyde-versus glutaraldehyde-processed porcine bioprostheses in the aortic valve position: long-term follow-up. Am J Cardiol 1984;54:681-682.
36. Rose AG. Pathology of the formalin-treated heterograft porcine aortic valve in the mitral position. Thorax 1972;27:401-409.
37. Rumisek JD, Albus RA, Clarke JS. Late mycobacterium chelonei bioprosthetic valve endocarditis: activation of implanted contaminant? Ann Thorac Surg 1985;39:277-279.
38. Christie GW. Anatomy of aortic heart valve leaflets: the influence of glutaraldehyde fixation on function. Eur J Cardiothorac Surg 1992;6:S25-S32.
39. Lee JM, Boughner DR, Courtman DW. The glutaraldehyde-stabilized porcine aortic valve xenograft. II. Effect of fixation with or without pressure on the tensile viscoelastic properties of the leaflet material. J Biomed Mater Res 1984;18:79-98.
40. Broom ND, Thompson FJ. Influence of fixation conditions on the performance of glutaraldehyde-treated porcine aortic valves. Towards a more scientific basis. Thorax 1979;34:166-176.
41. Hilbert SL, Barrick MK, Ferrans VJ. Porcine aortic valve bioprostheses: a morphologic comparison of the effects of fixation pressure. J Biomed Mater Res 1990;24:773-787.
42. Flomenbaum MA, Schoen FJ. Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves. J Thorac Cardiovasc Surg 1993;105:154-164.
43. Sacks MS, Smith DB, Hiester ED. The aortic valve microstructure: effects of transvalvular pressure. J Biomed Mater Res 1998;41:131-141.
44. Broom ND. An in-vitro study of mechanical fatigue in glutaraldehyde-treated porcine aortic valve tissue. Biomaterials 1980:1:3-8.
45. Gabbay S, Kadam P, Factor S, Cheung TK. Do heart valve bioprostheses degenerate for metabolic or mechanical reasons? J Thorac Cardiovasc Surg 1988;55:208-215.
46. Vesely I, Boughner D, Song T. Tissue buckling as a mechanism of bioprosthetic valve failure. Ann Thorac Surg 1988;46: 302-308.
47. Mayne AS, Christie GW, Smaill BH, Hunter PJ, Barratt-Boyes BG. An assessment of the mechanical properties of leaflets from four second-generation porcine bioprostheses with biaxial testing techniques. J Thorac Cardiovasc Surg 1989;98: 170-180.
48. Broom ND, Thomson FJ. Influence of fixation conditions on the performance of glutaraldehyde treated porcine aortic valves: towards a more scientific basis. Thorax 1979;34:166-176.
49. Duncan AC, Boughner D, Vesely I. Dynamic glutaraldehyde fixation of a porcine aortic valve xenograft. I. Effect of fixation conditions on the final tissue viscoelastic properties. Biomaterials 1996;17:1849-1856.
50. Morse D, Steiner RM. Cardiac valve identification atlas and guide. In: Morse D, Steiner RM, Fernandez J, editors. Guide to prosthetic cardiac valves. New York: Springer-Verlag; 1985. p 257-346.
51. Schoen FJ. Pathology of bioprostheses and other tissue heart valve replacements. In: Silver MD, editor. Cardiovascular pathology, 2nd ed. New York: Churchill Livingstone; 1991. p 1547-1605.
52. Ferrans VJ, Hilbert SL, Fujita S, et al. Abnormalities in explanted bioprosthetic cardiac valves. In: Virmani R, Atkinison JB, Fenoglio JJ, editors. Cardiovascular pathology, Philadelphia: WB Saunders; 1993. p 373-398.
53. Camilleri JP, Pornin B, Carpentier A. Structural changes of glutaraldehyde-treated porcine bioprosthetic valves. Arch Pathol Lab Med 1982;106:490-496.
54. Ishihara T, Ferrans VJ, Barnhart GR, Jones M, McIntosh CL, Roberts WC. Intracuspal hematomas in implanted porcine valvular bioprostheses. J Thorac Cardiovasc Surg 1982;83: 399-407.
55. Ferrans VJ, Tomita Y, Hilbert SL, Jones M, Roberts WC. Pathology of bioprosthetic cardiac valves. Hum Pathol 1987;18: 586-595.
56. Ishihara T, Ferrans VJ, Jones M, Boyce SW, Roberts WC. Occurrence and significance of endothelial cells in implanted porcine bioprosthetic valves. Am J Cardiol 1981;48:443-454.
57. Gendler E, Gendler S, Nimni ME. Toxic reactions evoked by glutaraldehyde-fixed pericardium and cardiac valve tissue bioprosthesis. J Biomed Mater Res 1984;18:727-736.
58. Huang-Lee LLH, Cheung DT, Nimni ME. Biochemical changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived crosslinks. J Biomed Mater Res 1990;24:1185-1201.
59. Eybl E, Grimm M, Grabenwoger M, BockP, Muller MM, Wolner E. Endothelial cell lining of bioprosthetic heart valve materials. J Thorac Cardiovasc Surg 1992;104:763-769.
60. Grabenwoger M, Sider J, Fitzal F, Zelenka C, Windberger U, Gromm M, Moritz A, Bock P, Wolner E. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material. Ann Thorac Surg 1996;62:772-777.
61. Shemin RJ, Schoen FJ, Hein R, Austin J, Cohn LH. Hemodynamic and pathologic evaluation of a unileaflet pericardial bioprosthetic valve. J Thorac Cardiovasc Surg 1988;95:912-919.
62. Walker DK, Scotten LN, Hewgill DE, Racca RG, Brownlee RT. Development and in-vitro assessment of a new two-leaflet replacement heart valve designed using computer-generated bubble surfaces. Med Biol Eng Comput 1983;21:31-38.
63. Schoen FJ, Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprostheses: implications for the mechanisms of bioprosthetic tissue mineralization. Am J Pathol 1986;123:134-145.
64. Mannschott P, Herbage D, Weiss M, Buffevant C. Collagen heterogeneity in pig heart valves. Biochem Biophys Acta. 1976;434:177-183.
65. Ishihara T, Ferrans VJ, Jones M, Boyce SW, Kawanami O, Roberts WC. Histologic and ultrastructural features of normal human parietal pericardium. Am J Cardiol 1980;46:744-753.
66. Ishihara T, Ferrans VJ, Jones M, Boyce SW, Roberts WC. Structure of bovine parietal pericardium and of unimplanted Ionescu-Shiley pericardial valvular bioprostheses. J Thorac Cardiovasc Surg 1981;81:747-757.
67. Jamieson WR, Munro AI, Miyagishima RT, Allen P, Burr LH, Tyers GF. Carpentier-Edwards standard porcine bioprosthesis: clinical performance to seventeen years. Ann Thorac Surg 1995;60:999-1006.
68. Cohn LH, Collins JJ, DiSesa VJ, Couper GS, Peigh PS, Kowalker W, Allred E. Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements. Ann Surg 1989;210:435-442.
69. Grunkemeier GL, Jamieson WR, Miller DC, Starr A. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovasc Surg 1994;108:709-718.
70. Milano A, Guglielmi C, De Carlo M, Di Gregorio O, Borzoni G, Verunelli F, Bortolotti U. Valve-related complications in elderly patients with biological and mechanical aortic valves. Ann Thorac Surg 1998;66:S82-S87.
71. Bolooki H, Kaiser GA, Mallon SM, Palatianos GM. Comparison of long-term results of Carpentier-Edwards and Hancock bioprosthetic valves. Ann Thorac Surg 1986;42:494-499.
72. Schoen FJ, Kujovich JL, Webb CL, Levy RJ. Chemically determined mineral content of explanted porcine aortic valve bioprostheses: correlation with radiographic assessment of calcification and clinical data. Circulation 1987;76:1061-1066.
73. Schoen FJ, Hobson CE. Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Hum Pathol 1985;16: 549-559.
74. Schoen FJ, Levy RJ. Bioprosthetic heart valve failure: pathology and pathogenesis. Cardiol Clin 1984;2:717-739.
75. Schoen FJ, Levy RJ. Pathophysiology of bioprosthetic heart valve calcification. In: Bodnar E, Yacoub MH, editors. Biological and bioprosthetic valves. New York: Yorke; 1986. p 418-429.
76. Allard MF, Thompson CR, MacNab JS, et al. Commissural region dehiscence from stent-posts of Carpentier-Edwards bioprosthetic cardiac valves. Cardiovasc Pathol 1995;4:155-162.
77. Schoen FJ, Fernandez J, Gonzalez-Lavin L, Cernaianu A. Causes of failure and pathologic findings in surgically removed Ionescu-Shiley standard bovine pericardial heart valve bioprostheses: emphasis on progressive structural deterioration. Circulation 1987;76:618-627.
78. Walley VM, Keon WJ. Patterns of failure in Ionescu-Shiley bovine pericardial bioprosthetic valves. J Thorac Cardiovasc Surg 1987;93:925-933.
79. McGonagle-Wolff K, Schoen FJ: Morphologic findings in explanted Mitroflow pericardial bioprosthetic valves. Am J Cardiol 1992;70:263-264.
80. Thiene G, Bortolotti U, Valente M, Milano A, Calabrese F, Talenti E, Mazzucco A, Gallucci V. Mode of failure of the Hancock pericardial valve xenograft. Am J Cardiol 1989;63: 129-133.
81. Walley VM, Rubens FD, Campagna M, Pipe AL, Keon WJ. Patterns of failure in Hancock pericardial bioprostheses. J Thorac Cardiovasc Surg 1991;102:187-194.
82. Hilbert SL, Ferrans VJ, McAllister HA, Cooley DA. IonescuShiley bovine pericardial bioprostheses: histologic and ultrastructural studies. Am J Pathol 1992;140:1195-1204.
83. Aupart MR, Sirinelli AL, Diemont FF, Meurisse YA, Dreyfus XB, Marchand MA. The last generation of pericardial valves in the aortic position: ten-year follow-up in 589 patients. Ann Thorac Surg 1996;61:615-620.
84. Cosgrove DM, Lytle BW, Taylor PC, Camacho MT, Stewart RW, McCarthy PM, Miller DP, Piedmonte MR, Loop FD. The Carpentier-Edwards pericardial aortic valve: ten-year results. J Thorac Cardiovasc Surg 1995;110:651-662.
85. Grunkemeier GL, Bodnar E. Comparative assessment of bioprosthesis durability in the aortic position. J Heart Valve Dis 1995;4:49-55.
86. Schoen FJ. Pathologic findings in explanted clinical bioprosthetic valves fabricated from photooxidized bovine pericardium. J Heart Valve Dis 1998;7:174-179.
87. Schoen FJ. Surgical pathology of removed natural and prosthetic heart valves. Hum Pathol 1987;18:558-567.
88. Ferrans FJ, Boyce SW, Billingham ME, Jones M, Ishihara T, Roberts WC. Calcific deposits in porcine bioprostheses: structure and pathogenesis. Am J Cardiol 1980;46:721-734.
89. Schoen FJ, Harasaki H, Kim KM, Anderson HC, Levy RJ. Biomaterial-associated calcification: pathology, mechanisms, and strategies for prevention. J Biomed Mater Res 1988;22:11-36.
90. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1983;113:143-155.
91. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 1985;52:523-532.
92. Schoen FJ, Hirsch D, Bianco RW, Levy RJ. Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep. J Thorac Cardiovasc Surg 1994;108:880-887.
93. Schoen FJ, Golomb G, Levy RJ. Calcification of bioprosthetic heart valves: a perspective on models. J Heart Valve Dis 1992; 1:110-114.
94. Mako WJ, Vesely I. In-vivo and in-vitro models of calcification in porcine aortic valve cusps. J Heart Valve Dis 1997;6: 316-323.
95. Bernacca GM, Fisher AC, Wilkinson R, Mackay TG, Wheatley DJ. Calcification and stress distribution in bovine pericardial heart valves. J Biomed Mater Res 1992;26:959-966.
96. Bernacca GM, Tobasnick G, Wheatley DJ. Dynamic in-vitro calcification of porcine aortic valves. J Heart Valve Dis 1994; 3:684-687.
97. Thubrikar MJ, Deck JD, Aouad J, Nolan SP. Role of mechanical stress in calcification of aortic bioprosthetic valves. J Thorac Cardiovasc Surg 1983;86:115-125.
98. Golomb G, Schoen FJ, Smith MS, Linden J, Dixon M, Levy RJ. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol 1987;127:122-130.
99. Grabenwoger M, Brock P, Fitzal F, Schmidberger A, Grimm M, Laufer G, Bergmeister H, Wolner E. Acidic glycoproteins accumulate in calcified areas of bioprosthetic tissue. J Heart Valve Dis 1998;7:229-234.
100. Levy RJ. Glutaraldehyde and the calcification mechanism of bioprosthetic heart valves. J Heart Valve Dis 1994;3:101-104.
101. Valente M, Bortolotti U, Thiene G. Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol 1985;119:12-21.
102. Majno G, Joris I. Cells, tissues and disease: principles of general pathology. Cambridge, MA: Blackwell Science; 1996, 229 p.
103. Levy RJ, Schoen FJ, Sherman FS, Nichols J, Hawley MA, Lund SA. Calcification of subcutaneously implanted type I collagen sponges: effects of glutaraldehyde and formaldehyde pretreatments. Am J Pathol 1986;122:71-82.
104. 3. Am J Pathol. To appear.
105. Girardot MN, Torraianni M, Girardot JMD. Effect of AOA on glutaraldehyde-fixed bioprosthetic heart valve cusps and walls: binding and calcification studies. Int J Artif Organs 1994;17:76-82.
106. Girardot MN, Torrianni M, Dillehay D, Girardot JM. Role of glutaraldehyde in calcification of porcine heart valves: comparing cusp and wall. J Biomed Mater Res 1995;29:793-801.
107. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation 1994;90:323-329.
108. Biedrzycki LM, Lerner E, Levy RJ, Schoen FJ. Differential calcification of cusps and aortic wall of failed stented porcine bioprosthetic valves. J Biomed Mater Res 1997;34:411-415.
109. Anderson HC. Molecular biology of matrix vesicles. Clin Orthop 1995;314:266-280.
110. Tomazic BB, Brown WE, Schoen FJ. Physicochemical properties of calcific deposits isolated from porcine bioprosthetic heart valves removed from patients following 2-13 years function. J Biomed Mater Res 1994;38:35-37.
111. Parhami F, Bostrom K, Watson K, Demer LL. Role of molecular regulation in vascular calcification. J Atheroscler Thromb 1996;3:90-94.
112. Schinke T, McKee MD, Karsenty G. Extracellular matrix calcification: where is the action?. Nat Genet 1999;21:150-151.
113. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G. Increased bone formation in osteocalcin-dependent mice. Nature 1996;382:448-452.
114. Wada T, McKee MD, Steitz S, Giachelli CM. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 1999; 84:166-178.
115. McKee MD, Nanci A. Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. Connect Tissue Res 1996;35:197-205.
116. Giachelli CM, Scatena M, Wada T. Osteopontin: potential roles in vascular function and dystrophic calcification. J Bone Miner Metab 1997;15:179-183.
117. Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla proteins: vitamin K-dependent proteins in bone. Physiol Rev 1989;69:990-1047.
118. Boskey AL. Matrix proteins and mineralization: an overview. Connect Tissue Res 1996;35:357-363.
119. Srivatsa SS, Harrity PJ, Maercklein PB, Kleppe L, Veinot J, Edwards WD, Johnson CM, Fitzpatrick LA. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest 1997;99:996-1009.
120. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, Otto CM. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995;92:8:2163-2168.
121. Broom ND. Fatigue-induced damage in glutaraldehyde-preserved heart valve tissue. J Thorac Cardiovasc Surg 1978; 76:202-211.
122. Broom ND, Marra D. Effect of glutaraldehyde fixation and valve constraint conditions on porcine aortic valve leaflet coaptation. Thorax 1982;37:620-626.
123. Sacks MS, Smith DB. Effects of accelerated testing on porcine bioprosthetic heart valve fiber architecture. Biomaterials 1998; 19:1027-1036.
124. Vyavahare N, Ogle M, Schoen FJ, Zand R, Gloeckner DC, Sacks M, Levy RJ. Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen structural denaturation and glycosaminoglycan loss. J Biomed Mater Res 1999;46:44-50.
125. Sacks MS, Schoen FJ. Calcification-independent collagen damage in explanted clinical porcine bioprosthetic heart valves. Trans Soc Biomater 1999;22:313.
126. Gloeckner DC, Billiar KL, Sacks MS. Effects of mechanical fatigue on the bending properties of the porcine bioprosthetic heart valve. ASAIO J 1999;45:59-63.
127. Purinya B, Kasyanov V, Volkolakov J, Latisis R, Tetere G. Biomechanical and structural properties of the explanted bioprosthetic valve leaflets. J Biomech 1994;27:1-11.
128. Simionescu A, Simionescu D, Deac R. Biochemical pathways of tissue degeneration in bioprosthetic cardiac valves: the role of matrix metalloproteinases. ASAIO 1996;42:M561-M567.
129. Simionescu D, Simionescu A, Deac R. Detection of remnant proteolytic activities in unimplanted glutaraldehyde-treated bovine pericardium and explanted cardiac bioprostheses. J Biomed Mater Res 1993;27:821-829.
130. Mako JW, Calabro A, Ratliff NB, Vesely I. Loss of glycosaminoglycans from implanted bioprosthetic heart valves. Circulation 1997;I-155.
131. Hunter GK. Role of proteoglycan in the provisional calcification of cartilage: a review and reinterpretation. Clin Orthop 1991;262:256-280.
132. Salgaller ML, Bajpai PK. Immunogenicity of glutaraldehyde-treated bovine pericardial tissue xenografts in rabbits. J Biomed Mater Res 1985;19:1-12.
133. Dahm M, Lyman WD, Schwell AB, Factor SM, Frater RW. Immunogenicity of glutaraldehyde-tanned bovine pericardium. J Thorac Cardiovasc Surg 1990;99:1082-1090.
134. Rocchini AP, Weesner KM, Heidelberger K, Keren D, Behrendt D, Rosenthal A. Porcine xenograft valve failure in children: an immunologic response. Circulation 1981;64:II162-II171.
135. Levy RJ, Schoen FJ, Howard SL. Mechanism of calcification of porcine bioprosthetic aortic valve cusps: role of T-lymphocytes. Am J Cardiol 1983;52:629-631.
136. Magilligan DJ Jr, Lewis JW Jr, Heinzerling RH, Smith D. Fate of a second porcine bioprosthetic valve. J Thorac Cardiovasc Surg 1983;85:362-370.
137. Mitchell RN, Jonas RA, Schoen FJ: Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg 1998;115:118-127.
138. Gimbrone MA Jr., Nagel T, Topper JN. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest 1997;99:1809-1813.
139. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999;340:1555-1564.
140. Vyavahare NR, Chen W, Joshi R, Lee CH, Hirsch D, Levy J, Schoen FJ, Levy RJ. Current progress in anticalcification for bioprosthetic and polymeric heart valves. Cardiovasc Pathol 1997;6:219-229.
141. Levy RJ, Schoen FJ, Lund SA, Smith MS. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy: experimental studies of optimal dosages and therapeutic durations. J Thorac Cardiovasc Surg 1987;94: 551-557.
142. Levy RJ, Wolfum J, Schoen FJ, Hawley MA, Lund SA, Langer R. Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate. Science 1985;228:190-192.
143. Levy RJ, Hawley MA, Schoen FJ, Lund SA, Liu PY. Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats. Circulation 1985;71:349-356.
144. Johnston TP, Webb CL, Schoen FJ, Levy RJ. Assessment of the in-vitro transport parameters for ethanehydroxy diphosphonate through a polyurethane membrane: a potential refillable reservoir drug delivery device. ASAIO J 1992;38:M611-M616.
145. Johnston T, Webb C, Schoen F, Levy R. Site-specific delivery of ethanehydroxy diphosphonate from refillable polyurethane reservoirs to inhibit bioprosthetic tissue calcification. J Control Rel 1993;25:227-240.
146. 3 in rat subdermal model studies. Am J Pathol 1991;138:971-981.
147. 3 preincubation. J Biomed Mater Res 1991;25:905-935.
148. Chen W, Kim JD, Schoen FJ, Levy RJ. Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde crosslinked porcine aortic valves. J Biomed Mater Res 1994;28:1485-1495.
149. Gott JP, Girardot M-N, Girardot, J-M, Hall JD, Whitlark JD, Horsley WS, Dorsey LM, Levy RJ, Chen W, Schoen FJ, Guyton RA. Refinement of the alpha aminooleic acid bioprosthetic valve anticalcification technique. Ann Thorac Surg 1997;64: 50-58.
150. Hirsch D, Drader J, Thomas TJ, Schoen FJ, Levy JT, Levy RJ. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and controlled release studies. J Biomed Mater Res 1993:27:1477-1484.
151. Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, Kruth HS, Zand R, Levy RJ. Prevention of bioprosthetic heart valve calcification by ethanol preincubation: efficacy and mechanism. Circulation 1997;95:479-488.
152. Vyavahare NR, Hirsch D, Lerner E, Baskin JZ, Zand R, Schoen FJ, Levy RJ. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res 1998;40:577-585.
153. Wilson GJ, Courtman DW, Klement P, Lee JM, Yeger H. Acellular matrix: a biomaterials approach for coronary artery and heart valve replacement. Ann Thorac Surg 1995;60:S353-S358.
154. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994;28:655-666.
155. Courtman DW, Pereira CA, Omar S, Langdon SE, Lee JM, Wilson GJ. Biomechanical and ultrastructural comparison of cryopreservation and a novel cellular extraction of porcine aortic valve leaflets. J Biomed Mater Res 1995;29:1507-1516.
156. Grabenwoger M, Grimm M, Ebyl E, Leukauf C, Muller MM, Plenck H Jr, Bock P. Decreased tissue reaction to bioprosthetic heart valve material after L-glutamic acid treatment: a morphological study. J Biomed Mater Res 1992;26:1231-1240.
157. Lee JM, Pereira CA, Kan LW. Effect of molecular structure of poly(glycidyl ether) reagents on crosslinking and mechanical properties of bovine pericardial xenograft materials. J Biomed Mater Res 1994;28:981-992.
158. Myers DJ, Nakaya G, Girardot MN, Christie GW. A comparison between glutaraldehyde and diepoxide-fixed stentless porcine aortic valves: biochemical and mechanical characterization and resistance to mineralization. J Heart Valve Dis 1995;4:S98-S101.
159. Vasudev SC, Chandy T. Effect of alternative crosslinking techniques on the enzymatic degradation of bovine pericardia and their calcification. J Biomed Mater Res 1997;35:357-369.
160. Xi T, Ma J, Tian W, Lei X, Long S, Xi B. Prevention of tissue calcification on bioprosthetic heart valve by using epoxy compounds: a study of calcification tests in vitro and in vivo. J Biomed Mater Res 1992;26:1241-1251.
161. Moore MA, Phillips RE. Biocompatibility and immunologic properties of pericardial tissue stabilized by dye-mediated photooxidation. J Heart Valve Dis 1997;6:307-315.
162. Schoen FJ, Levy RJ, Hubert SL, Bianco RW. Antimineralization treatments for bioprosthetic heart valves. J Thorac Cardiovasc Surg 1992;104:1285-1288.
163. David TE, Feindel CM, Scully HE, Bos J, Rakowski H. Aortic valve replacement with stentless porcine aortic valves: a tenyear experience. J Heart Valve Dis 1998;7:250-254.
164. Westaby S, Jin XY, Katsuma T, Arifi A, Baidley P. Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root. J Thorac Cardiovasc Surg 1998;116:477-484.
165. Jin XY, Dhital K, Bhattacharya K, Pieris R, Amarasena N, Pillai R. Five-year hemodynamic performance of the prima stentless aortic valve. Ann Thorac Surg 1998;66:805-809.
166. David TE, Puschmann R, Ivanov J, Bos J, Armstrong S, Feindel CM, Scully HE. Aortic valve replacement with stentless and stented porcine valves: a case-match study. J Thorac Cardiovasc Surg 1998;116:236-241.
167. Cleveland DC, Williams WG, Razzouk AJ, Trusler GA, Rebeyka IM, Duffy L, Kan Z, Coles JG, Freedom RM. Failure of cryopreserved homograft valved conduits in the pulmonary circulation. Circulation 1992;86(Suppl II):II-150-II-153.
168. Vrandecic M, Gontijo B, Fantini FA, Martins I, Oliveira MH, Avelar SS, Oliveira O, Vrandecic E. Porcine mitral stentless valve mid-term clinical results. Eur J Cardiothorac Surg 1997; 12:56-62.
169. O'Brien M, Stafford E, Gardner M, et al. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves with a note on chromosomal studies. J Thorac Cardiovasc Surg 1987;94:812-823.
170. Barratt-Boyes BG, Roche AHG, Subramanyan R, Pemberton JR, Whitlock RM. Long-term follow-up of patients with the antibiotic-sterilized aortic homograft valve inserted freehand in the aortic position. Circulation 1987;75:768.
171. Matsuki O, Robles A, Gibbs S, Ross DN. Long-term performance of 555 aortic homografts in the aortic position. Ann Thorac Surg 1988;46:187-191.
172. Kirklin JK, Smith D, Novick W, Naftel DC, Kirklin JW, Pacifico AD, Nanda NC, Helmcke FR, Bourge RC. Long-term function of cryopreserved aortic homografts. J Thorac Cardiovasc Surg 1993;106:154-165.
173. Tuna IC, Orszulak TA, Schaff HV, Danielson GK. Results of homograft aortic valve replacement for active endocarditis. Ann Thorac Surg 1990;49;619-624.
174. Hilbert SL, Luna RE, Zhang J, Wang Y, Hopkins RA, Yu ZX, Ferrans VJ. Allograft heart valves: the role of apoptosismediated cell loss. J Thorac Cardiovasc Surg 1999;117:454-462.
175. Angell W, Oury J, Lamberti J, Koziol J: Durability of the viable aortic allograft. J Thorac Cardiovasc Surg 1989;98:48.
176. Kouchoukos NT, Davila-Roman VG, Spray TL, Murphy SF, Perrillo JB. Replacement of the aortic root with a pulmonary autograft in children and young adults with aortic-valve disease. N Engl J Med 1994;330:1-6.
177. Chambers JC, Somerville J, Stone S, Ross DN. Pulmonary autograft procedure for aortic valve disease: long-term results of the pioneer series. Circulation 1997;96:2206-2214.
178. Love JW, Schoen FJ, Breznock EM, Shermer SP, Clove CS. Experimental evaluation of an autologous tissue heart valve. J Heart Valve Dis 1992;1:232-241.
179. Langer R, Vacanti JP. Tissue engineering. Science 1993;260: 920-926.
180. Mayer JE Jr, Shinoka T, Shum-Tim D. Tissue engineering of cardiovascular structures. Curr Opin Cardiol 1997;12:528-532.
181. Zund G, Hoerstrup SP, Schoeberlein A, Lachat M, Uhlschmid G, Vogt R, Turina M. Tissue engineering: a new approach in cardiovascular surgery; seeding of human fibroblasts followed by human endothelial cells on resorbable mesh. Eur J Cardo Thorac Surg 1998;13:160-164.
182. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, Langer R, Vacanti JP, Mayer JE Jr. Tissue-engineered heart valves: autologous valve leaflet replacement study in a lamb model. Circulation 1996;94:II-164 -II-168.
183. Shinoka T, Sum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, Vacanti JP, Mayer JE Jr. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998;115:536-545.
184. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J 1998;12:47-56.
185. Niklason LE, Gao J, Abbott VM, Hirsch KK, Houser S, Marini R, Langer R. Functional arteries grown in-vitro. Science 1999; 284:489-493.
186. Eisenberg LM, Markwald RR. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 1995;77:1-6.
187. Pexieder T. Conotruncus and its septation at the advent of the molecular biology era. In: Clark EB, Markwald RR, Takao A, editors. Developmental mechanisms of heart disease. Armonk, NY: Future; 1995. p 227-247.
188. Roy A, Brand NJ, Yacoub MH. Molecular characterization of interstitial cells isolated from human heart valves. In: World Symposium on Heart Valve Disease, London, June 12-14, 1999. p149.
189. Beresford A. Transdifferentiation and the vascular wall. In: Zilla P, Greisler HP, editors. Tissue engineering of vascular prosthetic grafts. Austin, TX: RG Landes; 1999. p 403-416.
190. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74.
191. Marron K, Yacoub MH, Polak JM, Sheppard MN, Fagan D, Whitehead BF, de Leval MR, Anderson RH, Wharton J. Innervation of human atrioventricular and arterial valves. Circulation 1996;94:368-375.